Oric Pharmaceuticals Inc
ORIC11.180USD
-0.260-2.27%
Close 07/28, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 07/29, 09:30 (ET)
794.66MMarket Cap
LossP/E TTM
Oric Pharmaceuticals Inc
11.180
-0.260-2.27%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Operating expenses
12.86%32.72M
25.91%39.57M
33.60%38.32M
44.11%36.02M
12.90%28.99M
42.09%31.43M
38.60%28.68M
20.76%24.99M
10.41%25.68M
-3.01%22.12M
12.13%20.69M
-1.71%20.70M
40.51%23.26M
38.97%22.80M
46.12%18.46M
89.31%21.06M
80.34%16.55M
87.09%16.41M
77.98%12.63M
75.03%11.12M
44.64%9.18M
--8.77M
--7.10M
--6.36M
--6.35M
R&D expenses
12.20%24.64M
30.59%31.97M
39.37%31.20M
54.04%28.94M
12.52%21.96M
50.24%24.48M
52.06%22.39M
35.80%18.79M
15.97%19.52M
-2.69%16.30M
14.14%14.72M
-10.85%13.83M
43.87%16.83M
38.24%16.75M
46.06%12.90M
100.92%15.52M
61.25%11.70M
74.04%12.11M
56.80%8.83M
53.23%7.72M
39.18%7.25M
--6.96M
--5.63M
--5.04M
--5.21M
Depreciation, depletion, and amortization
15.71%302.00K
15.59%304.00K
5.06%270.00K
5.02%272.00K
3.16%261.00K
6.48%263.00K
16.29%257.00K
4.86%259.00K
0.80%253.00K
7.86%247.00K
1.84%221.00K
11.26%247.00K
9.61%251.00K
-2.14%229.00K
-9.58%217.00K
-9.76%222.00K
-8.40%229.00K
-13.33%234.00K
-11.11%240.00K
0.00%246.00K
3.31%250.00K
--270.00K
--270.00K
--246.00K
--242.00K
Operating profit
-12.86%-32.72M
-25.91%-39.57M
-33.60%-38.32M
-44.11%-36.02M
-12.90%-28.99M
-42.09%-31.43M
-38.60%-28.68M
-20.76%-24.99M
-10.41%-25.68M
3.01%-22.12M
-12.13%-20.69M
1.71%-20.70M
-40.51%-23.26M
-38.97%-22.80M
-46.12%-18.46M
-89.31%-21.06M
-80.34%-16.55M
-87.09%-16.41M
-77.98%-12.63M
-75.03%-11.12M
-44.64%-9.18M
---8.77M
---7.10M
---6.36M
---6.35M
Net non-operating interest income (expenses)
Non-operating interest income
-32.22%2.70M
5.33%3.26M
17.10%3.75M
97.95%4.05M
129.60%3.98M
143.55%3.10M
270.40%3.20M
400.73%2.05M
1650.51%1.73M
3641.18%1.27M
2783.33%865.00K
1139.39%409.00K
125.00%99.00K
13.33%34.00K
200.00%30.00K
32.00%33.00K
-81.74%44.00K
-91.25%30.00K
-97.90%10.00K
-92.11%25.00K
-7.66%241.00K
--343.00K
--476.00K
--317.00K
--261.00K
Special income (expenses)
----
----
----
----
----
--0.00
100.00%0.00
----
----
--0.00
---5.00M
----
----
100.00%0.00
100.00%0.00
----
----
---11.87M
---12.97M
----
----
----
--0.00
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
100.00%0.00
-100.00%0.00
-79.73%15.00K
-100.00%0.00
-109.46%-7.00K
-38.89%44.00K
1.37%74.00K
-5.71%66.00K
--74.00K
--72.00K
--73.00K
--70.00K
Income before tax
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
-86.08%-16.51M
-238.27%-28.26M
-290.11%-25.55M
-84.81%-11.02M
-47.50%-8.87M
---8.35M
---6.55M
---5.96M
---6.01M
Income after tax
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
-86.08%-16.51M
-238.27%-28.26M
-290.11%-25.55M
-84.81%-11.02M
-47.50%-8.87M
---8.35M
---6.55M
---5.96M
---6.01M
Net income from continuous operations
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
-86.08%-16.51M
-238.27%-28.26M
-290.11%-25.55M
-84.81%-11.02M
-47.50%-8.87M
---8.35M
---6.55M
---5.96M
---6.01M
Net income attributable to controlling interests
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
-86.08%-16.51M
-238.27%-28.26M
-290.11%-25.55M
-84.81%-11.02M
-47.50%-8.87M
---8.35M
---6.55M
---5.96M
---6.01M
Net income attributable to common shareholders
-20.03%-30.02M
-28.16%-36.31M
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
8.45%-20.85M
-34.75%-24.83M
3.44%-20.29M
-40.28%-23.16M
19.42%-22.77M
27.88%-18.43M
-90.58%-21.01M
-86.08%-16.51M
-238.27%-28.26M
-290.11%-25.55M
-84.81%-11.02M
-47.50%-8.87M
---8.35M
---6.55M
---5.96M
---6.01M
Basic earnings per share
-13.80%-0.42
-4.35%-0.51
-10.40%-0.49
9.59%-0.45
30.07%-0.37
5.21%-0.49
29.25%-0.44
2.19%-0.50
9.58%-0.53
10.11%-0.52
-32.82%-0.63
10.24%-0.51
-30.49%-0.59
31.07%-0.58
43.95%-0.47
-55.38%-0.57
-51.70%-0.45
-949.24%-0.84
74.95%-0.84
-70.09%-0.37
-35.85%-0.30
---0.08
---3.36
---0.22
---0.22
Diluted earnings per share
-13.80%-0.42
-4.35%-0.51
-10.40%-0.49
9.59%-0.45
30.07%-0.37
5.21%-0.49
29.25%-0.44
2.19%-0.50
9.58%-0.53
10.11%-0.52
-32.82%-0.63
10.24%-0.51
-30.49%-0.59
31.07%-0.58
43.95%-0.47
-55.38%-0.57
-51.70%-0.45
-949.24%-0.84
74.95%-0.84
-70.09%-0.37
-35.85%-0.30
---0.08
---3.36
---0.22
---0.22
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
